Rituximab Outcomes and Predictors of Treatment Failure in Primary Membranous Nephropathy: A Retrospective Cohort Study
Background/Objectives: Rituximab (RTX) is an established treatment for primary membranous nephropathy (PMN); however, real-world data on predictors of response and the influence of previous treatment status remain limited. We evaluated outcomes and predictors of treatment failure in PMN patients treated with RTX. Metho...